Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis-Reference-Cited by-同舟云学术

Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis

Published:2022-01-11 Issue:1 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Renton William D¹²³,Tiller Georgina¹²³,Munro Jane¹³,Tan Joachim³⁴,Johnston Renea V³,Avery Jodie C³⁵,Whittle Samuel L³⁶,Arno Anneliese³,Buchbinder Rachelle³

Affiliation:

1. Rheumatology Unit, Department of General Medicine; The Royal Children's Hospital; Melbourne Australia

2. Department of Paediatric Rheumatology; Monash Children's Hospital; Melbourne Australia

3. Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University; Monash-Cabrini Department of Musculoskeletal Health and Clinical Epidemiology; Cabrini Health; Melbourne Australia

4. Rheumatology Unit, Department of General Medicine; Queensland Children’s Hospital; Brisbane Australia

5. Adelaide Medical School, Robinson Research Institute; The University of Adelaide; North Adelaide Australia

6. Rheumatology Unit; Queen Elizabeth Hospital; Woodville South Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference52 articles.

1. Biological agents in polyarticular juvenile idiopathic arthritis: a meta-analysis of randomized withdrawal trials;Amarilyo;Seminars in Arthritis and Rheumatism,2016

2. Clinical trial design in juvenile idiopathic arthritis;Balevic;Paediatric Drugs,2017

3. Brooker J Synnot S McDonald S Elliott JE Turner T the Living Evidence Network Guidance for the production and publication of Cochrane living systematic reviews: Cochrane Reviews in living mode (Version December 2019) Available at //community.cochrane.org/sites/default/files/uploads/inline-files/Transform/201912_LSR_Revised_Guidance.pdf

4. Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis;Bulatović Ćalasan;Rheumatology,2014

5. The development of classification criteria for children with juvenile rheumatoid arthritis;Cassidy;Bulletin on the Rheumatic Diseases,1989

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis;Pediatric Rheumatology;2022-07-23